Citation: Sr. Denmeade et Jt. Isaacs, ENZYMATIC ACTIVATION OF PRODRUGS BY PROSTATE-SPECIFIC ANTIGEN - TARGETED THERAPY FOR METASTATIC PROSTATE-CANCER, The cancer journal from Scientific American, 4, 1998, pp. 15-21
Authors:
DENMEADE SR
NAGY A
GAO J
LILJA H
SCHALLY AV
ISAACS JT
Citation: Sr. Denmeade et al., ENZYMATIC ACTIVATION OF A DOXORUBICIN-PEPTIDE PRODRUG BY PROSTATE-SPECIFIC ANTIGEN, Cancer research, 58(12), 1998, pp. 2537-2540
Authors:
JOSEPH IBJK
NELSON JB
DENMEADE SR
ISAACS JT
Citation: Ibjk. Joseph et al., ANDROGENS REGULATE VASCULAR ENDOTHELIAL GROWTH-FACTOR CONTENT IN NORMAL AND MALIGNANT PROSTATIC TISSUE, Clinical cancer research, 3(12), 1997, pp. 2507-2511
Citation: Xs. Lin et al., MECHANISM AND ROLE OF GROWTH ARREST IN PROGRAMMED (APOPTOTIC) DEATH OF PROSTATIC-CANCER CELLS INDUCED BY THAPSIGARGIN, The Prostate, 33(3), 1997, pp. 201-207
Authors:
DENMEADE SR
LOU W
LOVGREN J
MALM J
LILJA H
ISAACS JT
Citation: Sr. Denmeade et al., SPECIFIC AND EFFICIENT PEPTIDE-SUBSTRATES FOR ASSAYING THE PROTEOLYTIC ACTIVITY OF PROSTATE-SPECIFIC ANTIGEN, Cancer research, 57(21), 1997, pp. 4924-4930
Citation: Sr. Denmeade et al., ROLE OF PROGRAMMED (APOPTOTIC) CELL-DEATH DURING THE PROGRESSION AND THERAPY FOR PROSTATE-CANCER (VOL 28, PG 251, 1996), The Prostate, 28(6), 1996, pp. 6-6
Citation: Sr. Denmeade et al., ROLE OF PROGRAMMED (APOPTOTIC) CELL-DEATH DURING THE PROGRESSION AND THERAPY FOR PROSTATE-CANCER, The Prostate, 28(4), 1996, pp. 251-265